chr2-127702034-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_032740.4(SFT2D3):āc.506C>Gā(p.Thr169Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000726 in 1,239,436 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000040 ( 0 hom., cov: 33)
Exomes š: 0.0000028 ( 0 hom. )
Consequence
SFT2D3
NM_032740.4 missense
NM_032740.4 missense
Scores
7
9
3
Clinical Significance
Conservation
PhyloP100: 3.18
Genes affected
SFT2D3 (HGNC:28767): (SFT2 domain containing 3) Predicted to be involved in protein transport and vesicle-mediated transport. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
WDR33 (HGNC:25651): (WD repeat domain 33) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This gene is highly expressed in testis and the protein is localized to the nucleus. This gene may play important roles in the mechanisms of cytodifferentiation and/or DNA recombination. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.887
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SFT2D3 | NM_032740.4 | c.506C>G | p.Thr169Arg | missense_variant | 1/1 | ENST00000310981.6 | NP_116129.3 | |
WDR33 | NM_018383.5 | c.*4289G>C | 3_prime_UTR_variant | 22/22 | ENST00000322313.9 | NP_060853.3 | ||
WDR33 | XM_011511436.2 | c.*4289G>C | 3_prime_UTR_variant | 22/22 | XP_011509738.1 | |||
WDR33 | XM_005263697.4 | c.*4459G>C | 3_prime_UTR_variant | 21/21 | XP_005263754.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SFT2D3 | ENST00000310981.6 | c.506C>G | p.Thr169Arg | missense_variant | 1/1 | 6 | NM_032740.4 | ENSP00000310803.3 | ||
WDR33 | ENST00000322313 | c.*4289G>C | 3_prime_UTR_variant | 22/22 | 1 | NM_018383.5 | ENSP00000325377.3 |
Frequencies
GnomAD3 genomes AF: 0.0000399 AC: 6AN: 150388Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
6
AN:
150388
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000275 AC: 3AN: 1089048Hom.: 0 Cov.: 31 AF XY: 0.00000575 AC XY: 3AN XY: 521764
GnomAD4 exome
AF:
AC:
3
AN:
1089048
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
521764
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000399 AC: 6AN: 150388Hom.: 0 Cov.: 33 AF XY: 0.0000273 AC XY: 2AN XY: 73390
GnomAD4 genome
AF:
AC:
6
AN:
150388
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
73390
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 15, 2021 | The c.506C>G (p.T169R) alteration is located in exon 1 (coding exon 1) of the SFT2D3 gene. This alteration results from a C to G substitution at nucleotide position 506, causing the threonine (T) at amino acid position 169 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
M
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Pathogenic
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Gain of MoRF binding (P = 0.0163);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at